Merck Reports 950 Pending NuvaRing Lawsuits: the Threat of Severe Adverse Events from NuvaRing remains

Share Article

As published on February 28th, 2012 in Merck & Co., Inc. form 10-K annual report for the fiscal year 2011, approximately 950 NuvaRing lawsuits were pending as of Dec. 31st 2011. The plaintiffs seek damages for injuries allegedly sustained from their NuvaRing use, including some alleged deaths, heart attacks and strokes. NuvaRing is a popular internal birth control device, a vaginal ring placed near the cervix that was approved by the FDA in 2001. In 2011, the FDA published a birth control study revealing that the NuvaRing raised the risk of blood clots by 56% when compared to older birth control pills. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of NuvaRing severe adverse events [http://www.attorneyone.com/nuva-ring-lawsuit/ .

NuvaRing severe adverse events threat

NuvaRing severe adverse events threat

plaintiffs seek damages for injuries allegedly sustained from their NuvaRing use, including deaths, heart attacks and strokes

The media spotlight is often a double-edged sword. No one knows this better than women who suffer from NuvaRing severe adverse events. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

As published on February 28th, 2012 in Merck & Co., Inc. form 10-K report for the fiscal year 2011, approximately 950 NuvaRing lawsuits were pending as of Dec. 31st 2011. The plaintiffs seek damages for injuries allegedly sustained from their NuvaRing use, including deaths, heart attacks and strokes. NuvaRing is a contraceptive that comes in the form of a vaginal ring using female hormones in an effort to prevent ovulation. NuvaRing was approved by the FDA in October 2001 and it is marketed and sold by subsidiaries of Merck, Organon USA Inc. and Schering-Plough. Potential NuvaRing Recall lawsuits for its adverse events can still be filed.

Approximately 820 cases are or will be pending in a federal multidistrict litigation (MDL 1964) in Missouri and approximately 125 are pending in coordinated discovery proceedings in the Bergen County Superior Court of New Jersey. The plaintiffs contend that Organon and Schering-Plough, among other things, failed to adequately design and manufacture NuvaRing and failed to adequately warn of the alleged increased risk of venous thromboembolism (“VTE”) posed by NuvaRing, and/or downplayed the risk of VTE. Four additional cases are pending in various other state courts.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of in case of NuvaRing severe adverse events, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat of severe adverse events from NuvaRing remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

In October 2011, the FDA published a study revealing that NuvaRing raised the risk of blood clots, including DVT and PE by 56% when compared to older birth control pills. According to Mayo Clinic, side effects of NuvaRing may include among others:

  •     Increased risk of blood-clotting problems, heart attack, stroke, liver cancer, gallbladder disease and high blood pressure
  •     Vaginal infection or irritation
  •     Breakthrough bleeding or spotting
  •     Weight gain
  •     Depression
  •     Decreased sex drive

AttorneyOne.com has further information on NuvaRing lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about NuvaRing at our website. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/4/prweb9390287.htm.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Attorney One
1-877-230-7343
Email >
Visit website